Tijuana injection drug users on collision course for HIV and TB

Apr 15, 2009

A study by researchers from the University of California, San Diego School of Medicine, in collaboration with Mexican researchers and health officials, shows that as many as 67 percent of injection drug users in Tijuana test positive for tuberculosis (TB) infection. The analysis, which underscores the urgent need for TB screening and treatment for populations that are also at risk for HIV infection, will be published in the May issue of the International Journal of Tuberculosis and Lung Disease (IJTLD).

"While users are known to be at risk for TB, this is one of the highest rates ever reported among this group," said principal investigator Richard Garfein, PhD, MPH, associate professor in the Division of Global Public Health and Department of Medicine at UC San Diego. The analysis is part of a bi-national, community-based study called Proyecto El Cuete that includes more than 1,000 illicit drug injectors residing in Mexico's largest U.S. border city.

What most concerns Garfein is that injection drug users are not only likely to have weakened immune system due to illicit drug use, but are also at high risk for HIV infection. This makes the situation much worse for individuals infected with TB, because HIV further weakens a patient's immune system.

Worldwide, tuberculosis is a leading cause of death among persons with AIDS. Once a person becomes infected from breathing in TB bacteria, the immune system generally encapsulates the bacteria and prevents it from growing. When this happens, the bacteria remain alive in an inactive state called latent TB infection. But the TB bacteria can become active at a later date if the person's is weakened, for example, in those with AIDS.

"Persons with latent TB infection are not sick and are not contagious," said co-investigator Dr. Rafael Laniado-Laborin, MD, chief of Tijuana General Hospital's clinic, adding that, in otherwise healthy individuals, the chance of the latent TB becoming active is about 10 percent over their lifetime. "However, if individuals become infected with HIV, their chance of developing active TB increases to 10 percent per year."

Once active, TB bacteria replicate in the lungs. Symptoms include coughing, which facilitates the airborne spread of bacteria to others.

"Given that two-thirds of Tijuana's injection drug users have latent TB infection, the majority of those who become HIV infected - a risk that is increasing - are also likely to develop active, contagious TB," said Garfein.

TB is endemic in Mexico, where children are routinely vaccinated with the Bacillus Calmett-Guerin (BCG) vaccine, which is not highly effective but can prevent some serious forms of childhood TB. Unfortunately, the vaccine can cause false-positive results with the tuberculin skin test (TST), used for over a century to detect TB infection. For this reason, estimates of TB prevalence using the TST are unreliable in areas of Mexico where the BCG vaccine is given, making it difficult to anticipate future health care needs for at-risk populations.

Instead of TST, participants in this study were given a TB test called interferon-gamma release assay (IGRA) which measures the substance released by sensitized immune cells when they are exposed to TB bacteria. Neither test can differentiate between latent and active TB. However, the IGRA is more sensitive and specific in testing for TB because it doesn't cross-react with the BCG vaccine.

Injection drug users, age 18 years or older, were asked about past TB diagnosis, illness and treatment as well as the presence of TB symptoms such as persistent cough, fever or chills, shortness of breath, fatigue and unexplained weight loss. Participants with TB symptoms were referred to a municipal health clinic for further evaluation.

Of the 1,025 participants who received IGRA results, 681 (67%) tested positive for TB, with 13 individuals reporting symptoms. Injection drug users recruited from two neighborhoods nearest the U.S./Mexico border had 64% higher odds of being IGRA-positive than non-drug users. These odds increased by 20% for every five years of reported injection drug use.

Additional years of residence in Tijuana were also associated with greater prevalence of IGRA-positive results. One explanation is that more time spent among other injection drugs users in Tijuana increased the likelihood of exposure to TB. Only 4% of study participants tested positive for HIV infection. However, if HIV is not controlled and its prevalence increases, the number of injection drug users whose latent TB infection becomes active is destined to increase, according to the researchers.

"This at-risk population urgently needs better screening and treatment for TB,"said Laniado-Laborin. "Treatment reduces the TB reactivation risk by nearly 75%, while cutting the death rate of patients with HIV and TB in half."

Source: University of California - San Diego (news : web)

Explore further: Syria hit by flesh-eating maggot disease

add to favorites email to friend print save as pdf

Related Stories

Researchers urge integrating TB into HIV care

Jul 22, 2008

In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention ...

HIV/AIDS linked to drug resistant TB

Nov 16, 2006

U.S. scientists say a highly drug-resistant form of tuberculosis has been linked to HIV/AIDS in a study conducted in rural South Africa.

Smoking increases risk of TB infection, study finds

Feb 27, 2007

People who smoke have a greater risk of becoming infected with tuberculosis (TB) and of having that infection turn into active TB disease, according to an analysis by researchers at the University of California, Berkeley.

New TB test reveals patients at risk, says study

Oct 20, 2008

A recently introduced blood test can reveal which patients may develop active tuberculosis (TB) much more precisely than the 100-year old TB skin test, according to a new study published today in the journal Annals of In ...

Recommended for you

Syria hit by flesh-eating maggot disease

15 hours ago

Three cases of myiasis have been reported near Damascus, marking the first appearance of the flesh-eating maggot disease in Syria, UN health experts said Friday.

Sperm can carry Ebola for 82 days: WHO

16 hours ago

Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.